Australia Antigen (Hepatitis-Associated Antigen)

1972; Wiley; Volume: 2; Issue: 3 Linguagem: Inglês

10.1111/j.1445-5994.1972.tb03076.x

ISSN

0004-8291

Autores

J. Vivian Wells, H. Hugh Fudenberg,

Tópico(s)

Hepatitis C virus research

Resumo

Australian and New Zealand Journal of MedicineVolume 2, Issue 3 p. 278-291 Australia Antigen (Hepatitis-Associated Antigen) J. Vivian Wells, Corresponding Author J. Vivian Wells Section of Hematology and Immunology, University of California, San Francisco. *Postdoctoral Fellow (USPHS Training Grant HL-05677).Section of Hematology and Immunology, University of California, San Francisco, California 94122, USA.Search for more papers by this authorH. Hugh Fudenberg, H. Hugh Fudenberg Section of Hematology and Immunology, University of California, San Francisco. †Professor of Medicine, University of California, San Francisco; Professor of Bacteriology and Immunology. University of California, Berkeley.Search for more papers by this author J. Vivian Wells, Corresponding Author J. Vivian Wells Section of Hematology and Immunology, University of California, San Francisco. *Postdoctoral Fellow (USPHS Training Grant HL-05677).Section of Hematology and Immunology, University of California, San Francisco, California 94122, USA.Search for more papers by this authorH. Hugh Fudenberg, H. Hugh Fudenberg Section of Hematology and Immunology, University of California, San Francisco. †Professor of Medicine, University of California, San Francisco; Professor of Bacteriology and Immunology. University of California, Berkeley.Search for more papers by this author First published: August 1972 https://doi.org/10.1111/j.1445-5994.1972.tb03076.xCitations: 5 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Blumberg, B. S. (1964): Polymorphisms of serum proteins and the development of isoprecipitins in transfused patients, Bull. N.Y. Acad. Med. 40, 377. 2 Blumberg, B. S., Melartin, L., Guinto, R. A., and Werner, B. (1966): Family studies of a “new” human serum isoantigen system (Australia antigen), Amer. J. hum. Genet. 18, 594. 3 Blumberg, B. S., Gerstley, B. J. S., Hungerford, D. A., London, W. T. and Sutnick, A. I. (1967): A serum antigen (Australia antigen) in Down's syndrome, leukemia and hepatitis, Ann. intern. Med. 66, 924. 4 Blumberg, B. S., Melartin, L., Lechat, M., and Guinto, R. S. (1967): Association between lepromatous leprosy and Australia antigen, Lancet 2, 173. 5 Okochi, K. and Murakami, S. (1968): Observations on Australia antigen in Japanese, Vox Sang. (Basel) 15, 374. 6 Prince, A. M. (1968): An antigen detected in the blood during the innoculation period of serum hepatitis, Prot. nat. Acad. Sci. (Wash.) 60, 814. 7 Levene, C., and Blumberg, B. S. (1969): Additional specificities of Australia antigen and the possible identification of hepatitis carriers, Nature (Lond.) 221, 195. 8 Blumberg, B. S., Sutnick, A. I., London, W. T. and Millinar, I. (1970): Current concepts: Australia antigen and hepatitis, New Engl. J. Med. 283, 349. 9 Maynard, J. E., Hartwell, W. V. and Berquist, K. R. (1971): Hepatitis-associated antigen in chimpanzees, J. infect. Dis. 123, 660. 10 Blumberg, B. S., Sutnick, A. I. and London, W. T. (1970): Australia antigen as a hepatitis virus. Variation in host response, Amer. J. Med. 48, 1. 11 Shulman, N. R. (1970): Hepatitis-associated antigen, Amer. J. Med. 49, 669. 12 Alter, H. J. and Blumberg, B. S. (1966): Further studies on a “new” human isoprecipitin system (Australia antigen), Blood 27, 297. 13 Bayer, M. E., Blumberg, B. S. and Werner, B. (1968): Particles associated with Australia antigen in the sera of patients with leukemia, Down's syndrome and hepatitis, Nature (Lond.) 218, 1057. 14 Hirschman, R. J., Shulman, N. R. and Barker, L. F. (1969): Virus-like particles in sera of patients with infectious and serum hepatitis, J. Amer. med. Ass. 208, 1667. 15 Zuckerman, A. J. (1969): Viral hepatitis and the Australia-SH antigen, Nature (London) 223, 569. 16 Gerin, J. L., Purcell, R. H. and Hoggan, M. D. (1969): Biophysical properties of Australia antigen, J. Virol. 4, 763. 17 Barker, L. F., Smith, K. O. and Gehle, W. D. (1969): Some antigenic and physical properties of virus-like particles in sera of hepatitis patients, J. Immunol. 102, 1529. 18 Dane, D. S., Cameron, C. H. and Briggs, M. (1970): Virus-like particles in serum of patients with Australia-antigen-associated hepatitis, Lancet 1, 695. 19 Jokelainen, P. T., Krohn, K., Prince, A. M. and Finlayson, N. D. C. (1970): Electron microscopic observations on virus-like particles associated with SH antigen, J. Virol. 6, 685. 20 Kim, C. Y. (1971): Hepatitis-associated antigen. Its biophysical properties and nucleic acid, Vox Sang. (Basel) 20, 440. 21 Hirschman, S. Z., Vernace, S. J. and Schaffner, F. (1971): DNA Polymerase in preparations containing Australia antigen, Lancet 1, 1099. 22 Kim, C. Y. and Bissell, D. M. (1971): Stability of the lipid and protein of hepatitis-associated (Australia antigen), J. infect. Dis. 123, 470. 23 Ashcavai, M. and Peters, R. L. (1971): Hepatitis-associated antigen: improved sensitivity in detection, Amer. J. clin. Path. 55, 262. 24 Gocke, D. J. and Howe, C. (1970): Rapid detection of Australia antigen by counterimmunoelectrophoresis, J. Immunol. 104, 1031. 25 Prince, A. M. and Burke, K. (1970): Serum hepatitis antigen (SH): Rapid detection by high voltage immunoelectrophoresis, Science 169, 593. 26 Wallis, C. and Melnick, J. L. (1971): Enhanced detection of Australia antigen in serum hepatitis patients by discontinuous counterimmunoelectrophoresis, Appl. Microbiol. 21, 867. 27 Merrill, D. A., Kohler, P. F. and Singleton, J. W. (1971): Quantitation of the hepatitis-associated antigen by electroimmunodiffusion, J. Allergy 47, 315. 28 Boenisch, T. and Katz, G. (1971): Hepatitis-associated antigen (HAA). I. Quantitation by electrophoresis in antibody-containing agarose gel by use of a primary standard of purified HAA, Clin. Chem. 17, 595. 29 Rightsel, W. A., Moore, H. A. and Muirhead, E. E. (1971): Electroprecipitin test for hepatitis-associated antigen and antibody, Amer. J. clin. Path. 55, 249. 30 Almeida, J. D. and Waterson, A. P. (1969): Immune complexes in hepatitis, Lancet 2, 983. 31 Kelen, A. E., Hathaway, A. E. and McLeod, D. A. (1971): Rapid detection of Australia/SH antigen and antibody by a simple and sensitive technique of immunoelectronmicroscopy, Canad. J. Microbiol. 17, 993. 32 Millman, I., Zavatone, V., Gerstley, B. J. S. and Blumberg, B. S. (1969): Australia antigen detected in the nuclei of liver cells of patients with viral hepatitis by the fluorescent antibody technique, Nature (Land.) 222, 181. 33 Coyne, V. E., Millman, I., Cerda, J., Gerstley The localization of Australia antigen by immunofluorescence. J. exp. Med. 131, 307. 34 Holper, J. C. and Jambazian, A. (1971): Comparative sensitivity of complement fixation, counterimmunoelectrophoresis, radial and double diffusion for detection of Australia antigen, Transfusion 11, 157. 35 Alter, H. J., Holland, P. V. and Purcell, R. H. (1971): Counterelectrophoresis for detection of hepatitis-associated antigen: methodology and comparison with gel diffusion and complement fixation, J. Lab. clin. Med. 77, 1000. 36 Schmidt, N. J. and Lennette, E. H. (1970): Complement fixation and immunodiffusion tests for assay of hepatitis-associated “Australia” antigen and antibodies, J. Immunol. 195, 604. 37 Walsh, J. H., Yalow, R. S. and Berson, S. A. (1970): Radioimmunoassay of Australia antigen. Vox Sang. (Basel) 19, 217. 38 Lander, J. J., Alter, H. J. and Purcell, R. H. (1971): Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique, J. Immunol. 106, 1166. 39 Hollinger, F. B., Vorndam, V. and Dreesman, G. R. (1971): Assay of Australia antigen and antibody employing double-antibody and solid-phase radioimmunoassay techniques and comparison with the passive hemagglutination methods, J. Immunol. 107, 1099. 40 Vyas, G. N. and Shulman, N. R. (1970): Hemagglutination assay for antigen and antibody associated with viral hepatitis, Science 170, 332. 41 Mayumi, M., Okochi, K. and Nishioka, K. (1971): Detection of Australia antigen by means of immune adherence haemagglutination test, Vox Sang. (Basel) 20, 178. 42 Schmidt, N. J., Gee, P. S. and Lennette, E. H. (1971): Relative sensitivity of gel diffusion, complement fixation, and immunoelectroosmophoresis tests for detection of hepatitis-associated antigen and antibody, Appl. Microbiol. 22, 165. 43 Gust, I. D. and Kaldor, J. (1971): An evaluation of the techniques used for the detection of Australia antigen and antibody Pathology 3, 151. 44 Hawkes, R. A. (1970): Australia antigen and viral hepatitis in Sydney, Med. J. Aust. 2, 519. 45 Ferris, A. A., Kaldor, J. and Lucas, C. R. (1970): Australia antigen and viral hepatitis: a brief review and a preliminary Australian report, Pathology 2, 1. 46 Mathews, J. D. and Mackay, I. R. (1970): Australia antigen in chronic hepatitis in Australia, Brit. med. J. 1, 259. 47 Gust, I. D. and Lucas, C. R. (1971): Australia antigen in acute hepatitis in Melbourne, Med. J. Aust. 1, 260. 48 Giles, J. P., McCollum, R. W., Berndtson, L. W. Jr., and Krugman, S. (1969): Viral hepatitis: relationship of Australia/SH antigen to the Willowbrook MS-2 strain, New Engl. J. Med. 281, 119. 49 Laiwah, A. C. Y., Goudie, R. B., Goldberg, D. M., Davidson, J. F. and Murray, T. S. (1970): Australia antigen in West of Scotland and North of England, Lancet 2, 121. 50 Cossart, Y. E. and Vahrman, J. (1970): Studies of Australia-SH antigen in sporadic viral hepatitis in London, Brit. med. J. 1, 403. 51 Neefe, J. R., Gellis, S. S. and Stokes, J. Jr. (1946): Homologous serum hepatitis and infectious (epidemic) hepatitis, Amer. J. Med. 1, 3. 52 Krugman, S., Giles, J. P. and Hammond, J. (1967): Infectious hepatitis: evidence for two distinctive clinical, epidemiological and immunological types of infection, J. Amer. med. Ass. 200, 363. 53 Lander, J. J., Giles, J. P., Purcell, R. H. and Krugman, S. (1971): Viral hepatitis, type B (MS-2 strain), detection of antibody after primary infection, New Engl. J. Med. 285, 303. 54 Shulman, N. R., Hirschman, R. J. and Barker, L. F. (1970): Viral hepatitis, Ann. intern. Med. 72, 257. 55 Prince, A. M. (1971): Role of serum hepatitis virus in chronic liver disease, Gastroenterology 60, 913. 56 Elling, P., Nielsen, J. O. and Dietrichson, O. (1970): Australia antigen in patients with various liver diseases, Acta path. microbiol. scand. 78, 657. 57 Prete, S. D., Costantino, D. Doglia, M., Graziina, A., Ajdukiewicz, A., Dudley, F. J., Fox, R. A. and Sherlock, S. (1970): Detection of a new serum-antigen in three epidemics of short-incubation hepatitis, Lancet 2, 579. 58 Krugman, S. K. and Giles, J. P. (1970): Viral hepatitis: new light on an old disease, J. Amer. med. Ass. 212, 1019. 59 Wright, R., McCollum, R. W. and Klatskin, G. (1969): Australia antigen in acute and chronic liver disease, Lancet 2, 117. 60 Sherlock, S., Fox, R. A., Niazi, S. P. and Schever, P. J. (1970): Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum, Lancet 1, 1243. 61 Mistilis, S. P. and Blackburn, C. R. B. (1970): Active chronic hepatitis, Amer. J. Med. 48, 484. 62 Wells, J. V. and Fudenberc, H. H. (1971): Metabolism of radioiodinated IgG in patients with abnormal serum IgG levels. I. Hypergamma-globulinemia, Clin. exp. Immunol. 9, 761. 63 Fox, R. A., Niazi, S. P. and Sherlock, S. (1969): Hepatitis-associated antigen in chronic liver disease, Lancet 2, 609. 64 Wright, R. (1970): The Australia antigen in chronic active hepatitis, Vox Sang. (Basel) 19, 320. 65 Krassnitzky, O., Pesendorfer, F. and Wewalka, F. (1970): Australia/SH antigen and lebererkrankungen, Dtsch. med. Wschr. 95, 249. 66 Vischer, T. L. (1970): Australia antigen and autoantibodies in chronic hepatitis, Brit. med. J. 2, 695. 67 Reinecke, V. and Nordenfeldt, E. (1970): Hepatitis-associated antigen in chronic liver disease, Lancet 1, 141. 68 Velasco, M. and Katz, R. (1970): Hepatitis-associated antigen and chronic liver disease, Lancet 1, 779. 69 Kaplan, M. M. and Grady, G. (1971): Serum hepatitis antigen in chronic hepatitis and primary biliary cirrhosis, Lancet 1, 159. 70 Gitnick, G. L., Gleich, G. J., Schoenfield, L. J., Baggenstoss, A. H., Sutnick, A. I., Blumberg, B. S., London, W. T. and Summerskill, W. H. J. (1969): Australia antigen in chronic active liver disease with cirrhosis, Lancet 2, 285. 71 Bulkley, B. H., Heizer, W. D., Goldfinger, S. E., Isselbacher, K. J. and Shulman, N. R. (1970): Distinctions in schronic active hepatitis based on circulating hepatitis-associated antigen, Lancet 2, 1323. 72 Prince, A. M., Leblanc, L., Krohn, K., Masseyeff, R. and Alpert, M. E. (1970): SH antigen and chronic sliver disease, Lancet 2, 717. 73 Prince, A. M. and Trepo, C. (1971): Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa, Lancet 1, 1309. 74 Ahmed, M. N., Huang, S.-N. and Spence, L. (1971): Australia antigen and hepatitis. An electron microscopic study, Arch. Path. 92, 66. 75 Williams, R. C. Jr., Kenyon, A. J. and Huntley, C. C. (1568): Immunoglobulins, viruses, and speculation on their interrelationships in certain human and animal disease states, Blood 31, 522. 76 Gocke, D. J. and Kavey, N. B. (1969): Hepatitis antigen: correlation with disease and infectivity of blood donors, Lancet 1, 1055. 77 Hadziyannis, S. J., Merikas, G. E. and Afroudakis, A. P. (1970): Hepatitis-associated antigen in chronic liver disease, Lancet 2, 100. 78 Maynard, E. P., Sadikali, F., Anthony, P. P. and Barker, L. F. (1970): Hepatitis-associated antigen and cirrhosis in Uganda, Lancet 2, 1326. 79 Krohn, K., Finlayson, N. D. C., Jokelainen, P. T., Anderson, K. E. and Prince, A. M. (1970): Electron microscopical and immunological observations on the serum hepatitis (S.H.) antigen in primary biliary cirrhosis, Lancet 2, 379. 80 Smith, I. B., and Blumberg, B. S. (1969): Viral hepatitis, postnecrotic cirrhosis and hepatocellular carcinoma, Lancet 2, 953. 81 Vogel, C. L., Anthony, P. P., Mody, N. and Barker, L. F. (1970): Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma, Lancet 2, 621. 82 Denison, E. K., Peters, R. L. and Reynolds, T. B. (1971): Familial hepatoma with hepatitis-associated antigen, Ann. intern. Med. 74, 391. 83 Houba, V., Allison, A. C., Hendrickse, R. G., Depetris, S., Edington, G. M. and Adeniyi, A. (1970): Immune complexes in the nephrotic syndrome of Nigerian children, in Proceedings of the International Symposium on Immune Complex Diseases, Carlo Erba Foundation, Milan , 1969. 84 Michael, A. F., Westberg, N. G., Fish, A. J. and Vernier, R. L. (1971): Studies on chronic membranoproliferative glemerulonephritis with hypocomplementemia. J. exp. Med. 134, 208s. 85 Munthe, E. and Natvig, J. B. (1970): Gammaglobulin complexes and anti-γ-globulin antibodies in rheumatoid tissue and tissue eluates, in Proceedings of the International Symposium on Immune Complex Diseases, Carlo Erba Foundation, Milan , 1969. 86 Kaplan, M. H. and Frengley, J. D. (1969): Autoimmunity to the heart in cardiac disease, Amer. J. Cardiol. 24, 459. 87 Combes, B., Stastny, P., Shorey, J., Eigenbrodt, E. H., Barrera, A., Hull, A. R. and Carter, N. W. (1971): Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane, Lancet 2, 234. 88 Gocke, D. J., Hsu, K., Morgan, C., Bombardieri, S., Lockshin, M. and Christian, C. L. (1970): Vasculitis in association with Australia antigen. J. exp. Med. 134, 330s. 89 Sutnick, A. I., Levine, P. H., London, W. T. and Blumberg, B. S. (1971): Frequency of Australia antigen in patients with leukaemia in different countries, Lancet 1, 1200. 90 Turk, J. L. and Bryceson, A. D. M. (1971): Immunological phenomena in leprosy and related diseases, Advanc. Immunol. 13, 209. 91 Jones, P. O., Goldsmith, H. J., Wright, F. K., Roberts, C. and Watson, D. C. (1967): Viral hepatitis, a staff hazard in a dialysis unit, Lancet 1, 835. 92 Knight, A. H., Fox, R. A., Baillod, R. A., Niazi, S. P., Sherlock, S. and Moorhead, J. F. (1970): Hepatitis-associated antigen and antibody in haemodialysis patients and staff, Brit. med. J. 3, 603. 93 Nordenfelt, E., Lindholm, T. and Dahlquist, E. (1970): A hepatitis epidemic in a dialysis unit. Occurrence and persistence of Australian antigen among patients and staff, Acta path. microbial. scand. 78, 692. 94 Nelson, M. and Cooke, B. (1971): The incidence of Australia antigen in blood donors and in certain high-risk patient populations, Med. J. Aust. 1, 950. 95 Sutnick, A. I., London, W. T., Millman, I., Gerstley, B. J. S. and Blumberg, B. S. (1971): Ergasteric hepatitis: endemic hepatitis associated with Australia antigen in a research laboratory, Ann. intern. Med. 75, 35. 96 Sutnick, A. I., London, W. T. and Blumberg, B. S. (1971): Australia antigen: a genetic basis for chronic liver disease and hepatoma, Ann intern. Med. 74, 442. 97 Cherubin, C. E. and Prince, A. M. (1971): Serum hepatitis specific antigen (SH) in commercial and volunteer sources of blood, Transfusion 11, 25. 98 Cherubin, C. E. (1971): Risk of post-transfusion hepatitis in recipients of blood containing S.H. antigen at Harlem hospital, Lancet 1, 627. 99 Kliman, A., Reid, N. R., Lilly, C. and Morrison, J. (1971): Hepatitis-associated antigen (Australia antigen) in Massachusetts blood donors, New Engl. J. Med. 285, 783. 100 Okochi, K., Murakami, S., Ninomiya, K. and Kaneko, M. (1970): Australia antigen, transfusion and hepatitis, Vox Sang. (Basel) 18, 289. 101 Sutnick, A. I., Cerda, J. J., Toskes, P. P., London, W. T. and Blumberg, B. S. (1971): Australia antigen and viral hepatitis in drug abusers, Arch. intern. Med. 127, 939. 102 Barker, L. F. and Murray, R. (1971): Acquisition of hepatitis-associated antigen. Clinical features in young adults, J. Amer. med. Ass. 216, 1970. 103 Grady, G. F. (1970): Prevention of post transfusion hepatitis by ν-globulin: preliminary report: a co-operative study, J. Amer. med. Ass. 214, 140. 104 Spellberg, M. A. and Berman, P. M. (1971): The incidence of post-transfusion hepatitis and the lack of efficacy of gamma globulin In its prevention, Amer. J. Gastroent. 55, 564. 105 Prince, A. M., Szmuness, W., Woods, K. R. and Grady, G. F. (1971): Antibody against serum-hepatitis antigen, New Engl. J. Med. 285, 933. 106 Seeler, R. A. and Mufson, M. A. (1971): Development and persistence of antibody to hepatitis-associated (Australia) antigen in patients with haemophilia, J. infect. Dis. 123, 279. 107 Hawkes, R. A. (1971): Failure of Australia antibody to prevent infectious hepatitis, Med. J. Aust. 1, 390. 108 Krugman, S., Giles, J. P. and Hammond, J. (1971): Viral hepatitis type B (MS-2 strain): prevention with specific hepatitis B-γ-globulin, J. Amer. med. Ass. 218, 1665. 109 Stokes, J. Jr. (1971): Usefulness of immuhe serum globulin in viral hepatitis, New Engl. J. Med. 285, 967. 110 Katz, R., Rodriguez, J. and Ward, R. (1971): Post-transfusion hepatitis-effect of modified gamma globulin added to blood in vitro, New Engl. J. Med., 285, 925. 111 Conrad, M., Young, A., Conrad, P., Park, R., Bancroft, W. and Bernier, G. (1971): Prophylactic use of gammaglobulin to prevent endemic viral hepatitis, J. clin. Invest. 50, 21a. 112 Hinman, J. and Tullis J. L. (1971): Implications of red cell washing for hepatitis transmission, Vox Sang. (Basel) 20, 440. 113 Krugman, S., Giles, J. P. and Hammond, J. (1971): Viral hepatitis, Type B (MS-2 strain): Studies on active immunization, J. Amer. med. Ass. 217, 41. 114 Chalmers, T. C. and Alter, H. J. (1971): Management of the asymptomatic carrier of the hepatitis-associated (Australia) antigen, New Engl. J. Med. 285, 613. Citing Literature Volume2, Issue3August 1972Pages 278-291 ReferencesRelatedInformation

Referência(s)